In the Pipeline: Encorafenib and Binimetinib in BRAF-Mutated Melanoma

Flaherty, K

Flaherty, K (reprint author), Harvard Med Sch, Med, Boston, MA 02115 USA.

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2017; 15 (10): 745